Dr. Cosgrove is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3651 Ridge Mill Dr
Hilliard, OH 43026Phone+1 614-293-3873Fax+1 614-293-3078
Education & Training
Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 2012 - 2016
Florida State University College of MedicineClass of 2012
Certifications & Licensure
OH State Medical License 2012 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma Start of enrollment: 2023 Oct 17
Roles: Principal Investigator, Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- 7 citationsPathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations.David A. Barrington, Ashley S. Felix, Rieham Owda, Adrian A. Suarez, David W. Cohen
Surgical Oncology. 2020-09-01 - 15 citationsThe prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.Casey Cosgrove, David E. Cohn, Jennifer Rhoades, Ashley S. Felix
Gynecologic Oncology. 2019-06-01 - 2 citationsMixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic...Ian S Hagemann, Wei Deng, Richard J Zaino, Matthew A Powell, Camille Gunderson Jackson
Gynecologic Oncology. 2023-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
